0.34%| Prev Close: | 35.50 |
|---|---|
| Open: | 35.90 |
| Bid: | 32.49 x 100 |
| Ask: | 39.27 x 100 |
| 1y Target Est: | 34.50 |
| Beta: | -0.213 |
| Next Earnings Date: | N/A |
| Day's Range: | 35.15 - 36.14 |
|---|---|
| 52wk Range: | 11.05 - 37.80 |
| Volume: | 342,651 |
| Avg Vol (3m): | 185,787 |
| Market Cap: | 1.15B |
| P/E (ttm): | N/A |
| EPS (ttm): | -3.44 |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Are These Top Post-IPO Performers Still a Buy?at Motley Fool(Tue 10:48AM EDT)
- The Best- And Worst- Performing Biotech Stocks, May 10 To May 17at Forbes(Sun, May 19)
- 3 Humongous Health-Care Stocks This Weekat Motley Fool(Sat, May 18)
- 4 Healthcare Stock Stories For Thursday Investing Wellnessat Wall St. Cheat Sheet(Thu, May 16)
- Why Tesaro Shares Vaulted Higherat Motley Fool(Thu, May 16)
- TESARO rises after data support advancement of drug to Phase 3 trialsat theflyonthewall.com(Thu, May 16)
- TESARO Announces Presentation of Niraparib Clinical Data at the 2013 ASCO Annual MeetingGlobeNewswire(Thu, May 16)
- TESARO, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersEDGAR Online(Thu, May 9)
- TESARO Announces Election of Dr. James Armitage to Board of Directors and Results of Annual Stockholder MeetingGlobeNewswire(Thu, May 9)
- Netupitant Results Could Roil Tesaro In Mayat Seeking Alpha(Mon, May 6)
- [video] You Ask, Cramer Answers! Buy Trius?at CNBC(Fri, May 3)
- TESARO, INC. FinancialsEDGAR Online Financials(Wed, May 1)
- Large Market Opportunity in Hepatitis C from a Volume Perspective: Brian Skorney Discusses Pockets in the Hepatitis C Space Where Companies Other Than Gilead (GILD) Will See ValueWall Street Transcript(Mon, Apr 29)
- The Best- And Worst-Performing Biotech Stocks, April 19 to April 26at Forbes(Sat, Apr 27)
- TESARO, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online(Fri, Apr 26)
Press Releases
- TESARO Announces Presentation of Niraparib Clinical Data at the 2013 ASCO Annual MeetingGlobeNewswire(Thu, May 16)
- TESARO Announces Election of Dr. James Armitage to Board of Directors and Results of Annual Stockholder MeetingGlobeNewswire(Thu, May 9)
- Tesaro Announces First-Quarter 2013 Operating ResultsGlobeNewswire(Thu, Apr 25)
Reports
- ValuEngine Industry Report for Medical-drugsValuEngine, Inc.(May 21)
- ValuEngine Detailed Valuation Report for TSROValuEngine, Inc.(May 16)
- TESARO INC (TSRO) Zacks Company SnapshotZacks Investment Research Inc.(May 15)